Brut Classic Antiperspirant And Deodorant Aerosol, Spray
FDA Label NDC 81277-012
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Sodalis Usa, Llc for the product Brut Classic Antiperspirant And Deodorant (NDC 81277-012). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding drug facts, active ingredient, purpose, use, warnings, do not use, ask a doctor before use, when using this product, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Active Ingredient
Aluminum Chlorohydrate 10%
Purpose
Antiperspirant
Use
reduces underarm wetness
Warnings
For external use only.
Flammable
- do not spray near flame or while smoking
- contents under pressure
- do not crush, puncture or incinerate
- do not store at temperature above 120°F
Do Not Use
on broken skin
Ask A Doctor Before Use
if you have kidney disease
When Using This Product
- keep away from face and mouth to avoid breathing it
- avoid spraying in eyes
- use only as directed; intentional misuse by deliberately concentrating and inhaling the contents can be harmful or fatal
Stop Use If
rash or irritation occurs
Keep Out Of Reach Of Children.
If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- apply to underarms only
- hold can about 6 inches away from underarm and spray.
Inactive Ingredients:
Isobutane, Cyclopentasiloxane, Hydrofluorocarbon 152A, Propane, Dimethicone, Propylene Carbonate, Disteardimonium Hectorite, Butane, Fragrance (Parfum), Amyl Cinnamal, Benzyl Alcohol, Benzyl Salicylate, Butylphenyl Methylpropional, Citronellol, Coumarin, Geraniol, Hexyl Cinnamal, Hydroxycitronellal, Hydroxyisohexyl-3-Cyclohexene Carboxaldehyde, Limonene, Linalool.
Questions?
1-800-575-7960
www.brutworld.com
Package Labeling:
* Please review the disclaimer below.